These final results, along with a past report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,two support the concept of concentrating on ACKR3 as a novel way to modulate the opioid process, which could open up new therapeutic avenues for opioid